Stribild (Elvitegravir/Cobicistat/FTC/Tenofovir): News
- AIDS Healthcare Foundation Challenges Gilead Over AIDS Drug Price Gouging of U.S. Government Programs on Stribild (February 1, 2013)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Stribild (the Quad) Approved in Canada (November 28, 2012)
From Canadian AIDS Treatment Information Exchange
- Stribild Gets FDA Approval as New Single-Tablet Regimen (November/December 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- FDA Approves Quad in U.S.: Price May Prohibit UK Access (September/October 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
 Stribild ("Quad") Recommended as Alternative First-Line HIV Treatment Regimen by U.S. Guidelines Panel (September 18, 2012)
From TheBody.com
- ADAP Crisis Task Force and Gilead Sciences Agree on Stribild Pricing for ADAPs (September 10, 2012)
In Positively Aware, from Test Positive Aware Network
- Stribild Included in Co-Pay and Assistance Programs (September 10, 2012)
In Positively Aware, from Test Positive Aware Network
 Thoughts on "Quad" Approval by FDA (August 28, 2012)
From Journal Watch
On TheBodyPRO.com
- Food and Drug Administration Approves Once-a-Day Pill for HIV (August 28, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
 Stribild (a.k.a. "Quad") Approved by FDA for First-Line Use; Becomes Third Single-Pill Regimen (August 27, 2012)
From U.S. Food and Drug Administration
- AIDS Pill's Price Draws Criticism (August 23, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Gilead Warned by Democrats Over "Quad" Pricing (August 17, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
 U.S. FDA Panel Recommends Gilead's Quad for HIV (May 14, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- May 11 FDA Advisory Committee Meeting: Fixed-Dose Combination Tablet of Elvitegravir/ Cobicistat/ Emtricitabine/ Tenofovir Disoproxil Fumarate (March 26, 2012)
From U.S. Food and Drug Administration
- Gilead and J&J Expand HIV Cocktail Partnership (November 16, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Lofty Hopes Confront Gilead's Four-Drug HIV Pill (September 12, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
|
Advertisement
|
Email
Glossary
